Three independent discounted-cash-flow-style models value Sabra Healthcare REIT, Inc. every trading day. 0 of 3 currently price SBRA above its market price.
| Free Cash Flow model | $13.47 |
| Excess Profit model | $-78.27 |
| Residual Earnings model | $-4.54 |
| Dividend Discount model | $26.58 |
| Piotroski F-Score | 5 / 9 |
| Return on invested capital | +2.3% |
| Net debt / EBITDA | 16.5× |
| Gross margin | +65.0% |
| Revenue CAGR | +10.8% |
| Cash conversion | 2.2× |
| Dividend yield | +6.3% |
| Buyback yield | -4.4% |
These are StockKitty's default assumptions. In the app, the models recompute live as you adjust growth, discount rates, and margins — and the AI explains the bull case, bear case, and quality picture.
Open SBRA in StockKitty